Finance

Lists
Why is CRBP down 2.04%?
Dive Deeper
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
$ 5.27
-2.04%
(-0.11) 1D
10-р сарын 12, 16:00:02 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
$ 5.35
High
$ 5.40
Low
$ 5.11
Mkt. cap
101.93 сая
Avg. vol.
1.19 сая
Volume
1.01 сая
52-wk high
$ 20.56
52-wk low
$ 5.11
EPS
-$ 6.17
Beta
2.63
Shares outstanding
19.34 сая
No. of employees
36
Open
$ 5.35
High
$ 5.40
Low
$ 5.11
Mkt. cap
101.93 сая
Avg. vol.
1.19 сая
Volume
1.01 сая
52-wk high
$ 20.56
52-wk low
$ 5.11
EPS
-$ 6.17
Beta
2.63
Shares outstanding
19.34 сая
No. of employees
36
News stories
From web sources and news partners
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
Founded2009 оны 1-р сарын 1
Headquarters-
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to CRBP in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current $ 5.27
$ 48.00 (+810.82%)
Average
$ 36.67 (+595.83%)
Lowest
$ 30.00 (+469.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
$ 30.00
+469.3%
09/15/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$ 35.00
+564.1%
09/15/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
09/14/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$ 38.00
+621.1%
09/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$ 33.00
+526.2%
09/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$ 36.00
+583.1%
08/12/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$ 48.00
+810.8%
08/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$ 48.00
+810.8%
08/07/2026
Paul Jeng
Guggenheim
Buy
Maintained
$ 45.00
+753.9%
06/02/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$ 38.00
+621.1%
05/13/2026
Maury Raycroft
Jefferies
Buy
Maintained
$ 33.00
+526.2%
05/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
$ 28.00
+431.3%
04/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
20.86 сая
18.41 сая
19.82 сая
31.18 сая
Cost of revenue
20.86 сая
18.41 сая
19.82 сая
31.18 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.56 сая
3.56 сая
4.48 сая
5.02 сая
Operating expense
3.56 сая
3.56 сая
4.48 сая
5.02 сая
Total operating expenses
24.42 сая
21.97 сая
24.30 сая
36.19 сая
Operating income
-24.42 сая
-21.97 сая
-24.30 сая
-36.19 сая
Other non operating income
-50.00 мян
-1.10 сая
-67.00 мян
-11.00 мян
EBT including unusual items
-23.34 сая
-20.56 сая
-22.97 сая
-35.04 сая
EBT excluding unusual items
-23.34 сая
-21.66 сая
-22.97 сая
-35.04 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23.34 сая
-20.56 сая
-22.97 сая
-35.04 сая
Net profit margin
-
-
-
-
Earnings per share
-1.90
-1.25
-1.23
-1.81
Interest and investment income
1.12 сая
1.41 сая
1.40 сая
1.16 сая
Interest expense
-
-
-
-
Net interest expenses
1.12 сая
1.41 сая
1.40 сая
1.16 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.37 сая
-21.92 сая
-24.26 сая
-36.14 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс